NEWSROOM Press Releases

Search Title:

Media Advisory: Dr. Heinrich Roder, Biodesix CTO, To Speak At Precision Medicine World Conference

January 19, 2018

Media Advisory: Dr. Heinrich Roder, Biodesix CTO, to speak at precision medicine world conference

Data Published In AACR Journal Suggest Biodesix® Test in Development May Identify Melanoma Patients Who Could Benefit from Checkpoint Inhibitors

December 20, 2017

Findings in the AACR Journal on melanoma patient outcomes after anti PD1 therapy; a serum protein signature predicted survival.

Biodesix’s Diagnostic Cortex™ Platform Used in Three Studies Presented at SITC

November 15, 2016

The study results indicate that the tests have the potential to offer clinically relevant information that could help physicians selecting immunotherapies for their patients make the best decision

Our Tests

Our Biopharma Services

How We Help

Diagnostic Solutions

Our Purpose

For Providers

For Research

For Patients

Patients

Office Hours:

NEWSROOM Press Releases

Media Advisory: Dr. Heinrich Roder, Biodesix CTO, To Speak At Precision Medicine World Conference

Data Published In AACR Journal Suggest Biodesix® Test in Development May Identify Melanoma Patients Who Could Benefit from Checkpoint Inhibitors

Biodesix’s Diagnostic Cortex™ Platform Used in Three Studies Presented at SITC